Vitamin D may be key for pregnant women with polycystic ovary syndrome

(University of Pennsylvania School of Medicine) Vitamin D may play a key role in helping some women seeking treatment for polycystic ovary syndrome (PCOS)-related infertility get pregnant. PCOS is a hormonal disorder affecting 5 to 10 percent of women of reproductive age. Results of the study show women who were Vitamin D deficient when starting fertility treatments were 40 percent less likely to achieve a pregnancy.
Source: EurekAlert! - Social and Behavioral Science - Category: International Medicine & Public Health Source Type: news

Related Links:

(Reuters Health) - Cigarette use decreased among young women - including pregnant women - during the past decade in the U.S., according to a new study. But, researchers found, use of marijuana blunts rose.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
This study showed that decidualized endometrial stromal cells own a lower stiffness and roughness compare to the ESCs. The acquisition of these properties could be important for the implantation stage during pregnancy, letting decidual ESCs act as an invasion-limiting barrier to contain the advance of the blastocyst and being a supportive structures that sustain the blastocyst avoiding miscarriages.
Source: Nanomedicine: Nanotechnology, Biology and Medicine - Category: Nanotechnology Source Type: research
Bayer announced Friday that it will no longer sell a controversial, permanent form of birth control that thousands of women say led to serious complications. Essure, a non-surgical sterilization device that is inserted into the fallopian tubes and prevents pregnancy by producing scar tissue that blocks sperm from fertilizing eggs, will no longer be available in the U.S. after December 31, 2018, Bayer announced in a statement. “This decision is based on a decline in U.S. sales of Essure in recent years and the conclusion that the Essure business is no longer sustainable,” the statement reads. While Bayer mainta...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized healthytime medicine onetime Source Type: news
The FDA said today that Bayer will no longer sell or distribute its Essure permanent birth control device in the US, effective December 31. FDA Commissioner Scott Gottlieb said the action follows a “series of earlier actions that the FDA took to address the reports of serious adverse events associated with its use,” according to an FDA release. “For women who have received an Essure implant, the postmarket safety of Essure will continue to be a top priority for the FDA. We expect Bayer to meet its postmarket obligations concerning this device,” Gottlieb said in a prepared statement. In April, the fe...
Source: Mass Device - Category: Medical Devices Authors: Tags: Regulatory/Compliance Women's Health Bayer Source Type: news
CONCLUSIONS: Unbalanced production of Cho signal in the follicular fluid may have occurred secondary to membrane damage of cumulus-oocyte-complexes due to CC therapy. PMID: 30024629 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
Conclusions: Among the fetuses transfused for B19V infection, 26% presented with prenatal abnormal cerebral imaging results. In our study, viral load in fetal blood appeared to be the only factor associated with fetal brain lesions.Fetal Diagn Ther
Source: Fetal Diagnosis and Therapy - Category: Perinatology & Neonatology Source Type: research
(MedPage Today) -- Depression during pregnancy tied to higher stress reactivity in children
Source: MedPage Today Psychiatry - Category: Psychiatry Source Type: news
A doctor may detect enlarged ovaries during an ultrasound or physical examination. The ovaries can become enlarged for several reasons, including ovulation, polycystic ovary syndrome, and benign cysts. In this article, learn more about the causes, symptoms, and treatment of enlarged ovaries, including during pregnancy.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Women's Health / Gynecology Source Type: news
The impact of vitamin D deficiency on the success of ovulation induction (OI) cycles and the risk pregnancy complications after OI has not been extensively investigated. The goal of this study was to evaluate the relationship between preconception vitamin D status and reproductive outcomes in women with a diagnosis of either PCOS or unexplained infertility treated with OI.
Source: Fertility and Sterility - Category: Reproduction Medicine Authors: Tags: Oral session Source Type: research
Conclusions: These results suggest that there is a seasonal driver for PE, with effects that are not modified by parity, latitude, fetal sex, or smoking. https://doi.org/10.1289/EHP963 Received: 14 August 2016 Revised: 24 January 2017 Accepted: 25 January 2017 Published: 29 June 2017 Address correspondence to C.R. Weinberg, Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709 USA. Telephone: (919) 541-4927. Email: weinber2@niehs.nih.gov Supplemental Material is available online (https://doi.org/10.1289/EHP963). The authors declare they h...
Source: EHP Research - Category: Environmental Health Authors: Tags: Research Source Type: research
More News: Hormones | Infertility | International Medicine & Public Health | Ovaries | Polycystic Ovary Syndrome | Pregnancy | Reproduction Medicine | Science | Study | University of Pennsylvania | Vitamin D | Vitamin D Deficiency | Vitamins | Women